Hyperbaric Oxygen as Adjunctive Therapy in Experimental Mediastinitis

Journal of Surgical Research

Volumn 155, Issue 1, 2009, Pages 111-115

  Turhan, Vedat ^a   Sacar, Suzan ^b   Uzun, Gunalp ^a   Sacar, Mustafa ^b   Yildiz, Senol ^a   Ceran, Nurgul ^c   Gorur, Rauf ^a   Oncul, Oral ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Department of Infectious Diseases and Clinical Microbiology   (Turkey)

Author keywords

hyperbaric oxygen therapy; linezolid; mediastinitis; teicoplanin; vancomycin

Indexed keywords

LINEZOLID; TEICOPLANIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL INFECTION; HYPERBARIC OXYGEN; LOADING DRUG DOSE; MALE; MEDIASTINITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS INFECTION; STERNOTOMY;

ACETAMIDES; ANIMALS; ANTI-INFECTIVE AGENTS; COMBINED MODALITY THERAPY; HYPERBARIC OXYGENATION; MALE; MEDIASTINITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; TEICOPLANIN; VANCOMYCIN;

EID: 67349173944     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.08.031     Document Type: Article

References (35)

1. Mediastinitis R.ME. In: Mandell G.L., Bennet J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. 6th ed. (2005), Elsevier Churchill Livingstone, Philadelphia, PA 1070-1078
2. Toumpoulis I.K., Anagnostopoulos C.E., and DeRose J.J. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest 127 (2005) 464
3. De Feo M., Gregorio R., Della Corte A., et al. Deep sternal wound infection: the role of early debridement surgery. Eur J Cardiothorac Surg 19 (2001) 811
4. Mekontso-Dessap A., Kirsch M., Brun-Buisson C., et al. Poststernotomy mediastinitis due to Staphylococcus aureus: Comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 32 (2001) 877
5. Hang L.W., Lien T.C., Wang L.S., et al. Hyperbaric oxygen as an adjunctive treatment for descending necrotizing mediastinitis: A case report. Zhonghua Yi Xue Za Zhi (Taipei) 60 (1997) 52
6. Salo J.A., Savola J.K., Toikkanen V.J., et al. Successful treatment of mediastinal gas gangrene due to esophageal perforation. Ann Thorac Surg 70 (2000) 2143
7. Institute of Laboratory Animal Resources National Research Council: Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
8. Kloos W.E., and Barnerman T.L. Staphylococcus and Micrococcus. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 7th ed. (1999), ASM Press, Washington 264-277
9. Ersoz G., Aytacoglu B., Sucu N., et al. Comparison and evaluation of experimental mediastinitis model: Precolonized foreign body implants and bacterial suspension inoculation seems promising. BMC Infect Dis 6 (2006) 76
10. Ogus T.N., Hulusi Us M., Cicek S., et al. Sternal cyanoacrylate gluing in mediastinitis. Effects on infection, stability and bone healing. J Cardiovasc Surg (Torino) 43 (2002) 741
11. Dailey C.F., Dileto-Fang C.L., Buchanan L.V., et al. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant. Staphylococcus aureus 2001:2304. Antimicrob Agents Chemother 45 (2001) 2304
12. Sacar M., Sacar S., Kaleli I., et al. Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: An experimental study. Int J Infect Dis 12 (2008) 396
13. Pavie J., Lefort A., Ploy M.-C., et al. Influence of reduced susceptibility to glycopeptide on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis. Antimicrob Agents Chemother 4 (2003) 2018
14. Finch R.G., and Eliopoulos G.M. Safety and efficacy of glycopeptide antibiotics. J Antimicrob Chemother 55 (2005) S5
15. Campoli-Richards D.M., Brodgen R.N., Faulds D., et al. Teicoplanin: A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs 40 (1990) 449
16. Smith T.L., Pearson M.L., Wilcox K.R., et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340 (1999) 493
17. Drew R.H. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy 27 (2007) 227
18. Stevens D.L., Dotter B., and Madaras-Kelly K. A review of linezolid: The first oxazolidinone antibiotic. Expert Rev Anti Infect Ther 2 (2004) 51
19. Wilcox M.H. Efficacy of linezolid versus comparator therapies in gram-positive infections. J Antimicrob Chemother 51 Suppl 2 (2003) ii27
20. Pasic M., Schaffarczyk R., and Hetzer R. Successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a heart transplant recipient. Eur J Cardiothorac Surg 25 (2004) 1127
21. Cheadle W.G. Risk factors for surgical site infection. Surg Infect (Larchmt) 7 Suppl 1 (2006) S7
22. Mader J.T., Brown G.L., Guckian J.C., et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 142 (1980) 915
23. Park M. Effect of hyperbaric oxygen in infectious diseases: Basic mechanisms. In: Kindwall E.P., and Whelan H.T. (Eds). Hyperbaric medicine practice. 2nd revised ed (2002), Best Publishing Company, Flagstaff, AZ 205-243
24. Walden W.C., and Hentges D.J. Differential effects of oxygen and oxidation-reduction potential on the multiplication of three species of anaerobic intestinal bacteria. Appl Microbiol 30 (1975) 781
25. Farr S.B., Touati D., and Kogoma T. Effects of oxygen stress on membrane functions in Escherichia coli: Role of HPI catalase. J Bacteriol 170 (1988) 1837
26. Hassan H.M., and Fridovich I. Superoxide radical and the oxygen enhancement of the toxicity of paraquat in Escherichia coli. J Biol Chem 253 (1978) 8143
27. Tsuneyoshi I., Boyle III W.A., Kanmura Y., and Fujimoto T. Hyperbaric hyperoxia suppresses growth of Staphylococcus aureus, including methicillin-resistant strains. J Anesth 15 (2001) 29
28. Lappa A., Malpieri M.R., Cicco M., et al. An alternative inexpensive treatment for deep sternal wound infections after sternotomy. Interact Cardiovasc Thorac Surg 2 (2003) 629
29. Mader J.T., Shirtliff M.E., Bergquist S.C., et al. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res 360 (1999) 47
30. Park M.K., Muhvich K.H., Myers R.A., et al. Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa. Antimicrob Agents Chemother 35 (1991) 691
31. Zamboni W.A., Mazolewski P.J., Erdmann D., et al. Evaluation of penicillin and hyperbaric oxygen in the treatment of streptococcal myositis. Ann Plast Surg 39 (1997) 131
32. Oztas E., Kilic A., Ozyurt M., et al. Effect of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb Med 28 (2001) 181
33. Mendel V., Reichert B., Simanowski H.J., et al. Therapy with hyperbaric oxygen and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Undersea Hyperb Med 26 (1999) 169
34. Mendel V., Simanowski H.J., and Scholz H.Ch. Synergy of HBO2 and a local antibiotic carrier for experimental osteomyelitis due to Staphylococcus aureus in rats. Undersea Hyperb Med 31 (2004) 407
35. Belhadj Amor M., Dakhlaoui J., Souissi H., et al. Hyperbaric oxygen therapy as an adjunctive treatment for acute mediastinitis due to esophageal perforation: A case report. Ann Fr Anesth Reanim 26 (2007) 862